Subcutaneous Implantable Defibrillator Therapy in Patients With Brugada Syndrome
JACC: Clinical Electrophysiology · 2025
DOI: 10.1016/j.jacep.2025.03.003 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2025. Verfasst von Federico Migliore und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac, Thoracic, and Vascular Sciences and Public Health University of Padova, Padova, Italy. Electronic address: federico.migliore@u…. Hauptthemen laut MEDLINE: Brugada Syndrome, Defibrillators, Implantable. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: The implantable cardioverter-defibrillator (ICD) is recognized as the most effective life-saving therapy in patients with Brugada syndrome (BrS). However, transvenous ICD is associated with a notable rate of complications over time. The subcutaneous implantable cardioverter-defibrillator (S-ICD) has emerged as a promising alternative to the transvenous ICD. Nevertheless, long-term data from large cohorts of BrS patients with S-ICDs are lacking. OBJECTIVES: This multicenter study aimed to assess the long-term outcomes of S-ICD therapy in patients with BrS. METHODS: The study included 450 consecutive BrS patients (mean age 43 ± 12; 86% male) who underwent S-ICD implantation between 2014 and 2024. RESULTS: During a median follow-up of 52 months (25th-75th percentile: 29-72), appropriate shocks were delivered in 3% of patients (1.2%; 95% CI: 0.2-2.2, at 12 months), with a first-shock success rate of 90% (100% with 2 shocks). Inappropriate shocks occurred in 7% of patients (1.4%; 95% CI: 0.3-2.5, at 12 months). Shock zone programmed at 250 beats/min (HR: 0.40; 95% CI: 0.18-0.89; P = 0.025) and more than 1 suitable vector on screening (HR: 0.39; 95% CI: 0.17-0.87; P = 0.023) were independent protective factors against inappropriate shock. Device-related complications were reported in 4% of patients (2.5%; 95% CI: 1.0-3.9 at 12 months). The need for antibradycardia pacing was reported in 3 patients (0.7%). No device explantation because of the need for antitachycardia pacing was noted. CONCLUSIONS: Our findings support the S-ICD as a viable alternative to the transvenous ICD for preventing sudden cardiac death in BrS patients without pacing indication (Arrhythmias Detection in a Real World Population [RHYTHM DETECT]; NCT02275637).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac, Thoracic, and Vascular Sciences and Public Health University of Padova, Padova, Italy. Electronic address: federico.migliore@unipd.it.
- Arrhythmia and Electrophysiology Unit, Cardiothoracic Department IRCCS Galeazzi - Sant' Ambrogio, Milan, Italy.
- Montevergine Clinic, Mercogliano, Avellino, Italy.
- Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli," Naples, Italy.
- Università Politecnica delle Marche, Ancona, Italy.
- Second Cardiology Division, Cardio-Thoracic and Vascular Department, University Hospital of Pisa, Pisa, Italy.
Zitieren
APA
Migliore, F., Ottaviano, L., Arestia, A., Nigro, G., Dello Russo, A., Viani, S., Bianchi, V., Bisignani, A., Pieragnoli, P., Vitulano, G., Rordorf, R., Francia, P., Taravelli, E., Pisanò, E., Lavalle, C., Brambilla, R., Ziacchi, M., Rapacciuolo, A., Viscusi, M., …, & S-ICD Rhythm Detect Investigators (2025). Subcutaneous Implantable Defibrillator Therapy in Patients With Brugada Syndrome. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2025.03.003
Vancouver
Migliore F, Ottaviano L, Arestia A, Nigro G, Dello Russo A, Viani S, et al. Subcutaneous Implantable Defibrillator Therapy in Patients With Brugada Syndrome. JACC: Clinical Electrophysiology. 2025. doi:10.1016/j.jacep.2025.03.003
BibTeX
@article{Migliore2025,
author = {Migliore, Federico and Ottaviano, Luca and Arestia, Alberto and Nigro, Gerardo and Dello Russo, Antonio and Viani, Stefano and Bianchi, Valter and Bisignani, Antonio and Pieragnoli, Paolo and Vitulano, Gennaro and Rordorf, Roberto and Francia, Pietro and Taravelli, Erika and Pisanò, Ennio and Lavalle, Carlo and Brambilla, Roberta and Ziacchi, Matteo and Rapacciuolo, Antonio and Viscusi, Miguel and De Filippo, Paolo and La Greca, Carmelo and Pepi, Patrizia and Notarstefano, Pasquale and Curcio, Antonio and Pittorru, Raimondo and Martini, Nicolò and Seganti, Alessandro and Napolitano, Carlo and Lovecchio, Mariolina and Valsecchi, Sergio and Botto, Gianluca and Priori, Silvia G and S-ICD Rhythm Detect Investigators, S-ICD Rhythm Detect Investigators},
title = {Subcutaneous Implantable Defibrillator Therapy in Patients With Brugada Syndrome},
journal = {JACC: Clinical Electrophysiology},
year = {2025},
doi = {10.1016/j.jacep.2025.03.003}
}
EUVIMED